CLINICAL_TRIALS
trial_result
· 2011-07-04
Clinical Trial Update: Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome [Phase 4]
Summary
Phase 4 trial evaluating the effect of Crestor (rosuvastatin) on lipid levels in patients with metabolic syndrome; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2011-07-04